The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market

The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market

Abstract

The combination of the bioscience industry with the information technology (IT) industry is emerging as an exciting industry segment that is being called bio-IT. Bioinformatics and biocomputing are other terms that sometimes mean the same thing as bio-IT. Companies involved in this interesting industry have made it possible for several genomics companies to sequence sections of the human genome as well as do work in proteomics. The bio-IT market is emerging at an important time when the bioscience companies need enormous computing power to make sense of the flood of data that is being generated in drug discovery R&D labs. Ironically, this is also an important time for the IT industry, which is hungry for new customers in the slow economy. This report seeks to review all the key elements of this interesting and important market.

For sellers of IT, this report is a call to action for IT vendors to join into the emerging bio-IT market because opportunities are plentiful. This is unusual in a slow economy. Unlike other industries, the bioscience companies take a long term view of their business, have cash to spend on IT infrastructure, need much help from IT firms and are ready, willing and able to get started in expanding their IT infrastructures for their R&D operations. The report estimates that the bio-IT market will reach nearly $27.7 billion in 2005 with a CAGR of 31.7 percent.

Readers will learn that clusters of ordinary, yet powerful PCs running Windows or Linux can produce good computational results at a lower cost than was possible just a few years ago with big high performance computers. In- silico disease modeling is helping to predict potential drug outcomes. The web is being used to find much-needed clinical trails participants.

For potential customers, this report uses case studies of bio-IT deployments to provide a sense of what IT solutions bioscience companies require. Profiles of bio-IT vendors highlight basic information about vendors that are offering key solutions in the emerging bio-IT market. This report highlights what is driving the need for bio-IT infrastructure and why. Readers will learn about key business opportunities and the lessons learned from the bio- IT experts. This 138-page report uses more than 34 tables and figures to show the trends of this emerging field.